NCT01670266View on ClinicalTrials.gov

Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma

PHASE1CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

May 31, 2013

Conditions

Ocular Hypertension (OHT)Mild Open Angle-glaucoma (OAG)

Interventions

DRUG

ONO-9054

DRUG

Placebo

Trial Locations (3)

92626

Costa Mesa Clinical Site, Costa Mesa

92663

Newport Beach (satellite site), Newport Beach

92705

Santa Ana (satellite site), Santa Ana

Sponsors

Lead Sponsor

Ono Pharma USA Inc

All Listed Sponsors

lead

Ono Pharma USA Inc

INDUSTRY